1) Diminished inflammatory cytokines such as IFN-γ & TNF-α, and alleviated symptoms of CRS.; 2) Prolonged overall survival in a mouse model of CAR T cell–induced CRS; 3) has been used to treat steroid-refractory CRS and severe CRS patients; 4) in clinical trials. Here, IFNG is linked to congenital rubella syndrome.